Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes - a review

Medicin og biovidenskab

• Blood Pressure 12%
• Exenatide 52%
• Glucagon-Like Peptide-1 Receptor 49%
• Glucose 12%
• Hypoglycemia 18%
• Incretins 100%
• Insulin Secretion 19%
• Insulin-Secreting Cells 20%
• Lipids 12%
• Liraglutide 54%
• Metabolic Diseases 20%
• Pharmaceutical Preparations 7%
• Pharmacology 12%
• Publications 15%
• PubMed 15%
• Quality of Life 12%
• Safety 11%
• Therapeutics 12%
• Type 2 Diabetes Mellitus 57%
• vascular factor 23%
• Weight Loss 15%